CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $37,943
- in 1 filing
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Spoor Johan M. Chief Executive Officer | Purchase | +47,000 | $0.81 | $38K | 106,383 |
| 2026-09-04 | Lantheus Alpha Therapy, LLC 10% owner | Sale | −167,149 | $3.15 | $526K | 11,273,364 |
| 2026-09-03 | Lantheus Alpha Therapy, LLC 10% owner | Sale | −80,783 | $3.11 | $251K | 11,440,513 |
| 2026-09-02 | Lantheus Alpha Therapy, LLC 10% owner | Sale | −42,129 | $3.11 | $131K | 11,521,296 |
| 2026-09-01 | Lantheus Alpha Therapy, LLC 10% owner | Sale | −35,769 | $3.12 | $112K | 11,563,425 |
| 2026-09-01 | Lantheus Holdings, Inc. 10% owner | Sale | −35,769 | $3.12 | $112K | 11,563,425 |
| 2026-08-31 | Lantheus Alpha Therapy, LLC 10% owner | Sale | −78,145 | $3.14 | $246K | 11,599,194 |
| 2026-08-31 | Lantheus Holdings, Inc. 10% owner | Sale | −78,145 | $3.14 | $246K | 11,599,194 |
| 2026-03-02 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2026-03-02 | Martinez Maria E Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2026-03-02 | Morich Frank Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2026-03-02 | Spoor Johan M. Chief Executive Officer | Grant or award · Stock option (right to buy) | +735,000 | 735,000 | ||
| 2026-03-02 | Williamson Robert F III Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2026-03-02 | Woods Lori A Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2026-03-02 | Hunt Jonathan Robert Chief Accounting Officer | Grant or award · Stock option (right to buy) | +90,000 | 90,000 | ||
| 2026-03-02 | HENSON HEIDI Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2025-11-13 | Hunt Jonathan Robert Chief Accounting Officer | Purchase | +11,000 | $2.03 | $22K | 59,800 |
| 2025-11-12 | Williamson Robert F III Director | Purchase | +9,498 | $2.10 | $20K | 9,864 |
| 2025-09-04 | Sendek Joel Chief Financial Officer | Grant or award · Stock option (right to buy) | +600,000 | 600,000 | ||
| 2025-09-03 | Martinez Maria E Director | Grant or award · Stock option (right to buy) | +75,000 | 75,000 |
Page 1 of 26 · 502 trades